Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Mindset Pharma Inc. (MSSTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.3500+0.0500 (+16.67%)
At close: 03:58PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.3000
Open0.3188
BidN/A x N/A
AskN/A x N/A
Day's Range0.3112 - 0.3500
52 Week Range0.2335 - 0.8416
Volume37,739
Avg. Volume21,839
Market Cap32.733M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for MSSTF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • MINDSET PHARMA INC
    Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total revenue is generated in the United States.
    Rating
    Fair Value
    Economic Moat
    3 days agoMorningstar
View more
  • Market Exclusive

    Weekly Roundup on the Cannabis Sector & Psychedelic Sector

    Key Takeaways; Cannabis Sector Institutional mortgage REIT AFC Gamma committed $82.5 million for Florida marijuana MSO Bloom Medicinals. Decibel announced Q4 results with strong revenue growth and sixth period of consecutive positive adjusted EBITDA. Red White & Bloom took steps to enhance its financial position. Key Takeaways; Psychedelic Sector Mindset Pharma strengthened its portfolio by […] The post Weekly Roundup on the Cannabis Sector & Psychedelic Sector appeared first on Market Exclusive

Advertisement
Advertisement